Management of melioidosis

@article{Wuthiekanun2006ManagementOM,
  title={Management of melioidosis},
  author={V. Wuthiekanun and S. Peacock},
  journal={Expert Review of Anti-infective Therapy},
  year={2006},
  volume={4},
  pages={445 - 455}
}
Melioidosis is a serious human infection caused by the environmental Gram-negative bacterium Burkholderia pseudomallei. Outcome following melioidosis remains poor despite 20 years of clinical research. Overall mortality is 50% in north-east Thailand (35% in children) and 19% in Australia. Relapse is common (13% over 10 years), and results from failure to eradicate the organism. Treatment is required to complete 12–20 weeks, or longer if clinically indicated. This is divided into intravenous and… Expand
The Treatment of Melioidosis
Melioidosis: a review.
The treatment of melioidosis: is there a role for repurposed drugs? A proposal and review
Laboratory diagnosis of melioidosis: Past, present and future
Evolution of Burkholderia pseudomallei in Recurrent Melioidosis
In vitro activity of BAL30072 against Burkholderia pseudomallei.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 96 REFERENCES
Interventions for treating melioidosis.
  • M. Samuel, T. Ti
  • Medicine
  • The Cochrane database of systematic reviews
  • 2001
Outcomes of Patients with Melioidosis Treated with Meropenem
Melioidosis: Epidemiology, Pathophysiology, and Management
Oral fluoroquinolones for maintenance treatment of melioidosis.
Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis.
  • P. Bossi, A. Tegnell, +5 authors G. Gouvras
  • Medicine
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2004
Septicaemic melioidosis: a review of 50 cases from Malaysia.
...
1
2
3
4
5
...